Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: taVNS Treatment for Fibromyalgia [NA]

View source ↗

Summary

A clinical trial is planned to evaluate taVNS (transcutaneous auricular vagus nerve stimulation) for fibromyalgia, with enrollment not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • taVNS (transcutaneous auricular vagus nerve stimulation)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Fibromyalgia | NA | Status: NOT_YET_RECRUITING